The topic of stenting in acute stroke may seem passé as a debate since the 2012 Food and Drug Administration clearance of the Solitaire FR revascularization device (Covidien, Mansfied, Massachusetts, USA). However, the concept has its origin in the use of permanent stents in the setting of recalcitrant acute stroke—which proved intriguing in both the potential for rapid restoration of flow and in the management of the peri-procedural antithrombotic medication regimen. Drs Fiorella and Woo compile for the reader the relatively short …